Shalini Sharp
2012 - Ultragenyx Pharmaceutical
In 2012, Shalini Sharp earned a total compensation of $303.5K as Chief Financial Officer and Senior Vice President at Ultragenyx Pharmaceutical.
Compensation breakdown
Non-Equity Incentive Plan | $51,560 |
---|---|
Option Awards | $90,042 |
Salary | $148,669 |
Other | $13,228 |
Total | $303,499 |
Sharp received $148.7K in salary, accounting for 49% of the total pay in 2012.
Sharp also received $51.6K in non-equity incentive plan, $90K in option awards and $13.2K in other compensation.
Rankings
In 2012, Shalini Sharp's compensation ranked 10,104th out of 11,487 executives tracked by ExecPay. In other words, Sharp earned more than 12.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,104 | 12th |
Manufacturing | 3,748 | 12th |
Chemicals And Allied Products | 1,048 | 13th |
Drugs | 801 | 13th |
Pharmaceutical Preparations | 607 | 13th |
Sharp's colleagues
We found two more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2012.